Leef Brands (LEEEF) EBIT (2025 - 2026)

Leef Brands (LEEEF) reported EBIT of $1.3 million for Q1 2026, up 167.29% on a YoY basis from $480245.0 in Q1 2025, and up 167.29% sequentially from -$1.9 million in Q1 2025.

Leef Brands (LEEEF) EBIT (2025 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 2 years of EBIT data on file, last reported at $1.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Mn
Mar 31, 2025 -1.91 Mn